Main page content

Displaying results 1 - 10 of 26
Publication ID: PEP20-06-02-001
Published:

This guide reviews interventions on treating substance misuse and substance use disorders (SUD) in youth with serious emotional disturbances (SED), distills the research into recommendations for practice, and provides examples of the ways that these recommendations can be implemented.

Publication ID: PEP20-03-02-001
Published:

The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).

Publication ID: PEP20-06-04-005
Published:

This Advisory is based on TIP 50, Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment. It provides strategies for identifying and addressing suicidal thoughts and behaviors among individuals with substance use disorders (SUDs).

Publication ID: PEP20-06-01-001
Published:

This guide supports health care providers, systems, and communities seeking to treat stimulant use disorders. It describes relevant research findings, examines best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.

Publication ID: SMA18-5054
Published:

This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.

Publication ID: SMA17-5044
Published:

This report presents 2016 national estimates of use of alcohol, tobacco products, illicit drugs (such as, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives), substance use disorders, and substance use treatment among people 12 years of age and older. It Includes national estimates of any mental illness, serious mental illness, major depressive episode, use of mental health services and suicidal ideation among adults ages 18 or older and national estimates of major depressive episode, use of mental health services among adolescents aged 12 to 17. Trend information on these topics are also presented.

Publication ID: SMA17-5029
Published:

This report highlights the structure, responsibilities, policies, services, and financing of single-state agencies and state mental health agencies. The report includes discussion of efforts to integrate physical and behavioral health and efforts by state agencies to address opioid abuse and misuse.

Publication ID: SMA16-5013
Published:

This comic book helps raise awareness about co-occurring disorders. It addresses negative public perceptions about the condition and available treatment options.

Publication ID: SMA16-4977
Published:

This advisory discusses the interaction between obsessive-compulsive disorder (OCD) and substance use disorder. It provides clinicians with an overview of screening and evidence-based treatments for OCD.

Publication ID: SMA16-4984
Published:

Summarizes key findings from the 2015 National Survey on Drug Use and Health (NSDUH) for indicators of substance use and mental health among people aged 12 years old or older in the civilian, non-institutionalized population of the United States.

Displaying 1 - 10 out of 26